Company news
Atricure, Inc. (NASDAQ:ATRC) news
Atricure, Inc. news releases on 6ix. Latest, Aug 25, 2026: AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
Press releases & updates
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
August 25, 2026
AtriCure Reports Second Quarter 2026 Financial Results
July 23, 2026
AtriCure to Announce Second Quarter 2026 Financial Results
July 1, 2026
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
May 27, 2026
AtriCure Reports First Quarter 2026 Financial Results
May 5, 2026
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
April 28, 2026
AtriCure to Announce First Quarter 2026 Financial Results
April 14, 2026
AtriCure to Participate in the Citizens Life Sciences Conference
February 23, 2026
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
February 17, 2026
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
January 26, 2026
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
January 11, 2026
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
December 16, 2025
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
December 10, 2025
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 17, 2025
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
October 28, 2025
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
October 27, 2025
AtriCure to Participate in Upcoming Investor Conferences
October 26, 2025
AtriCure to Announce Third Quarter 2025 Financial Results
October 7, 2025
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation
September 8, 2025
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
August 19, 2025
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
July 28, 2025
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 27, 2025
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
July 14, 2025
AtriCure to Announce Second Quarter 2025 Financial Results
July 7, 2025
AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 22, 2025
AtriCure Reports First Quarter 2025 Financial Results
April 28, 2025
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
April 9, 2025
AtriCure to Announce First Quarter 2025 Financial Results
April 7, 2025
AtriCure to Host Analyst & Investor Day on March 26, 2025
March 11, 2025
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
February 11, 2025
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results
January 21, 2025
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
January 12, 2025
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 22, 2024
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 19, 2024
AtriCure to Participate in the Stifel 2024 Healthcare Conference
November 6, 2024
AtriCure Reports Third Quarter 2024 Financial Results
October 28, 2024
AtriCure to Participate in the UBS Global Healthcare Conference
October 27, 2024
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
October 14, 2024
AtriCure to Announce Third Quarter 2024 Financial Results
October 7, 2024
AtriCure Receives CE-Mark for the EnCompass® Clamp
September 30, 2024
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
August 26, 2024
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
August 21, 2024
AtriCure Reports Second Quarter 2024 Financial Results
July 29, 2024
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
July 28, 2024
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
July 22, 2024
AtriCure to Announce Second Quarter 2024 Financial Results
July 8, 2024
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
May 14, 2024
AtriCure Reports First Quarter 2024 Financial Results
April 30, 2024
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
April 29, 2024
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
April 17, 2024